Cargando…

Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine Physicians

Nonvalvular atrial fibrillation- (NVAF-) related stroke and venous thromboembolism (VTE) are cardiovascular diseases associated with significant morbidity and economic burden. The historical standard treatment of VTE has been the administration of parenteral heparinoid until oral warfarin therapy at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peacock, W. Frank, Rafique, Zubaid, Singer, Adam J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884797/ https://www.ncbi.nlm.nih.gov/pubmed/27293895 http://dx.doi.org/10.1155/2016/1781684

Ejemplares similares

Practical Considerations for Use of Direct Oral Anticoagulants in Children
por: Whitworth, Hilary, et al.
Publicado: (2022)

Current treatment and unmet needs of hyperkalaemia in the emergency department
por: Rafique, Zubaid, et al.
Publicado: (2019)

Abstracts for the 39(th) Emergencies in Medicine Conference
por: Alali, Sukaina Ali, et al.
Publicado: (2021)

Direct-acting Oral Anticoagulants: An Overview
por: Salem, Hatem H.
Publicado: (2017)

Study design of Real World Evidence for Treatment of Hyperkalemia in the Emergency Department (REVEAL-ED): a multicenter, prospective, observational study
por: Rafique, Zubaid, et al.
Publicado: (2017)

Considerations for use of direct oral anticoagulants in arterial disease
por: Siegal, Deborah M., et al.
Publicado: (2021)

Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
por: Kustos, Stephanie A., et al.
Publicado: (2019)

Medications that interact with direct-acting oral anticoagulant exposure
por: de Vries, T. A. C., et al.
Publicado: (2021)

Direct oral anticoagulants: integration into clinical practice
por: Cowell, Richard P W
Publicado: (2014)

Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
por: Rose, Adam J., et al.
Publicado: (2021)

Hyperkalemia management in the emergency department: An expert panel consensus
por: Rafique, Zubaid, et al.
Publicado: (2021)

Abstracts for the 37(th) Annual Emergencies in Medicine Conference
por: Alali, Sukaina Ali, et al.
Publicado: (2020)

Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants
por: Gao, Lulu, et al.
Publicado: (2017)

Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome
por: Sexton, Donal J., et al.
Publicado: (2018)

Adding Herbal Products to Direct-Acting Oral Anticoagulants Can Be Fatal
por: Maadarani, Ossama, et al.
Publicado: (2019)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
por: Doucette, Kimberley, et al.
Publicado: (2020)

The use of direct acting oral anticoagulants in patients with COVID-19 infection
por: Aly, Ragia, et al.
Publicado: (2021)

Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review
por: Górnicki, Tomasz, et al.
Publicado: (2023)

Direct oral anticoagulant failure in stroke/transient ischaemic attack: neurologic and pharmacokinetic considerations
por: Rose, David Z, et al.
Publicado: (2020)

A Survey on the Awareness and Attitude of Physicians on Direct Oral Anticoagulants in Qatar
por: El-Bardissy, Ahmed, et al.
Publicado: (2018)

Diagnostic accuracy and temporal impact of ultrasound in patients with dyspnea admitted to the emergency department
por: Gaber, Heba R., et al.
Publicado: (2019)

Emergency Cardiac Surgery in Patients on Direct Oral Anticoagulants
por: De Paulis, Stefano, et al.
Publicado: (2022)

Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
por: Abdelnabi, Mahmoud, et al.
Publicado: (2022)

Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations
por: Lutz, Jens, et al.
Publicado: (2017)

Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double‐blind, Placebo‐controlled Study (ENERGIZE)
por: Peacock, W. Frank, et al.
Publicado: (2020)

Reversal of Oral Anticoagulants: A Survey of Contemporary Practice Trends (ReACT)
por: Deng, Huiwen, et al.
Publicado: (2023)

Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC): An update
por: Shah, Shagun B, et al.
Publicado: (2019)

Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase(®)
por: Sessa, Maurizio, et al.
Publicado: (2019)

Direct-Acting Oral Anticoagulants: A Resident-Based Workshop to Improve Knowledge and Confidence
por: Anderson, Irsk, et al.
Publicado: (2020)

Direct-acting Anticoagulants in Chronic Coronary Syndromes
por: Sorbets, Emmanuel, et al.
Publicado: (2020)

Practical considerations on non-vitamin K oral anticoagulants in patients with high body weight
por: Undas, Anetta
Publicado: (2016)

Management of hyperkalemia in the acutely ill patient
por: Dépret, François, et al.
Publicado: (2019)

Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
por: Ment, Jerome
Publicado: (2015)

Response to editorial comment ‘Direct oral anticoagulant failure in TIA/stroke: neurologic and pharmacokinetic considerations’
por: Huynh, Ronald, et al.
Publicado: (2020)

Alternative to oral dicoumarin anticoagulants: Considerations in dental care
por: Mingarro-de-León, Ana, et al.
Publicado: (2013)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Defining Acute Traumatic Encephalopathy: Methods of the “HEAD Injury Serum Markers and Multi-Modalities for Assessing Response to Trauma” (HeadSMART II) Study
por: Peacock, W. Frank, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ji3lchefr0rb1v6o02cnkucj9j